These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 33997033

  • 21. Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.
    Ye H, Wang LY, Zhao J, Wang K.
    World J Gastroenterol; 2013 May 14; 19(18):2818-25. PubMed ID: 23687420
    [Abstract] [Full Text] [Related]

  • 22. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 14; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 23. Expression of CD206 and CD163 on intermediate CD14++CD16+ monocytes are increased in hemorrhagic fever with renal syndrome and are correlated with disease severity.
    Li X, Du N, Xu G, Zhang P, Dang R, Jiang Y, Zhang K.
    Virus Res; 2018 Jul 15; 253():92-102. PubMed ID: 29857122
    [Abstract] [Full Text] [Related]

  • 24. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
    Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Sakai K, Inoue Y, Ihn H.
    Eur J Dermatol; 2012 Jul 15; 22(4):512-7. PubMed ID: 22576016
    [Abstract] [Full Text] [Related]

  • 25. Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis.
    Li J, Liu CH, Xu DL, Gao B.
    Am J Med Sci; 2015 Nov 15; 350(5):387-92. PubMed ID: 26379042
    [Abstract] [Full Text] [Related]

  • 26. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D, Yao Y, Yang C, Zhang S.
    Cancer Biomark; 2018 Feb 14; 21(3):689-700. PubMed ID: 29226859
    [Abstract] [Full Text] [Related]

  • 27. Monocyte implication in renal allograft dysfunction.
    Guillén-Gómez E, Guirado L, Belmonte X, Maderuelo A, Santín S, Juarez C, Ars E, Facundo C, Ballarín JA, Vidal S, Díaz-Encarnación MM.
    Clin Exp Immunol; 2014 Feb 14; 175(2):323-31. PubMed ID: 24134783
    [Abstract] [Full Text] [Related]

  • 28. The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.
    Kawarabayashi R, Motoyama K, Nakamura M, Yamazaki Y, Morioka T, Mori K, Fukumoto S, Imanishi Y, Shioi A, Shoji T, Emoto M, Inaba M.
    J Diabetes Res; 2017 Feb 14; 2017():6549242. PubMed ID: 29445750
    [Abstract] [Full Text] [Related]

  • 29. Increased levels of soluble CD163 in periodontitis patients.
    Detzen L, Chen SCY, Cheng B, Papapanou PN, Lalla E.
    J Clin Periodontol; 2017 Jun 14; 44(6):585-590. PubMed ID: 28419494
    [Abstract] [Full Text] [Related]

  • 30. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L, David MZ, Hyjek E, Chang A, Meehan SM.
    Clin J Am Soc Nephrol; 2015 Jan 07; 10(1):54-62. PubMed ID: 25516918
    [Abstract] [Full Text] [Related]

  • 31. CD163-positive macrophage infiltration predicts systemic involvement in sarcoidosis.
    Isohisa T, Asai J, Kanemaru M, Arita T, Tsutsumi M, Kaneko Y, Arakawa Y, Wada M, Konishi E, Katoh N.
    J Cutan Pathol; 2020 Jul 07; 47(7):584-591. PubMed ID: 32125018
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum levels of soluble CD163 in patients with systemic sclerosis.
    Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Ihn H.
    Rheumatol Int; 2012 Feb 07; 32(2):403-7. PubMed ID: 21120485
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H.
    Hepatology; 2014 Aug 07; 60(2):521-30. PubMed ID: 24623375
    [Abstract] [Full Text] [Related]

  • 36. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD.
    Nephrol Dial Transplant; 2004 Nov 07; 19(11):2761-8. PubMed ID: 15353578
    [Abstract] [Full Text] [Related]

  • 37. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity.
    Sporrer D, Weber M, Wanninger J, Weigert J, Neumeier M, Stögbauer F, Lieberer E, Bala M, Kopp A, Schäffler A, Buechler C.
    Eur J Clin Invest; 2009 Aug 07; 39(8):671-9. PubMed ID: 19490068
    [Abstract] [Full Text] [Related]

  • 38. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, Fujita H, Asano Y, Tada Y, Kadono T, Okochi H, Sato S.
    J Dermatol Sci; 2012 Oct 07; 68(1):45-51. PubMed ID: 22884782
    [Abstract] [Full Text] [Related]

  • 39. Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy.
    Hou J, Zhang M, Ding Y, Wang X, Li T, Gao P, Jiang Y.
    Mediators Inflamm; 2018 Oct 07; 2018():5270657. PubMed ID: 30034290
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.